REPOTRECTINIB vs RESTASIS: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
REPOTRECTINIB vs RESTASIS: Safety Overview
| Metric | REPOTRECTINIB | RESTASIS |
|---|---|---|
| Total FAERS Reports | 187 | 1,158 |
| Deaths Reported | 27 | 0 |
| Death Rate | 14.4% | N/A |
| Hospitalizations | 48 | 5 |
| Average Patient Age | 60.8 yrs | 66.9 yrs |
| % Female Patients | 61.1% | N/A |
| FDA Approval Date | Jun 11, 2024 | N/A |
| Manufacturer | E.R. Squibb & Sons, L.L.C. | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | N/A |